# Senaklear

NDC: 57237-371
Generic name: Sennosides
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN OTC DRUG
Marketing category: OTC monograph drug
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260930

FDA application: 505G(a)(3)

## Active ingredients

- SENNOSIDES: 8.6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57237-371"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57237-371